Today, BeautyHealth reports Q2 2023 financial results, delivering double-digit new sales growth, on demand for Hydrafacial. Based on the momentum, we reaffirm our 2023 net sales and long-term 2025 financial guidance, and refine our 2023 adjusted EBITDA margin to a more precise 18-19% range. On the results, BeautyHealth President and CEO Andrew Stanleick said: “In the second quarter, we recommitted to our core and, in doing so, delivered consistent performance and profitability in line with expectations. At the same, we are readying the organization for the next phase of growth, with a fortified executive team, robust innovation pipeline and disciplined approach to harnessing the enormous global market opportunity in front of us.” Read more: https://lnkd.in/gvAhG8ih #BeautyHealth #hydrafacial
Congrats!
Customer Success @ Quantum Metric 🐲 | Sales Passionate | Advisor
1yOutstanding job BeautyHealth 👏🏻👏🏻